| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 153.845 | 81 |
| GSM780708 | Untreated after 4 days (C2_1) | 162.663 | 81 |
| GSM780709 | Untreated after 4 days (C3_1) | 166.712 | 82 |
| GSM780719 | Untreated after 4 days (C1_2) | 155.026 | 81 |
| GSM780720 | Untreated after 4 days (C2_2) | 154.559 | 81 |
| GSM780721 | Untreated after 4 days (C3_2) | 124.61 | 78 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 165.753 | 82 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 155.537 | 81 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 148.817 | 80 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 143.561 | 80 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 160.035 | 81 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 165.376 | 82 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 169.08 | 82 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 152.972 | 81 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 169.391 | 82 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 169.531 | 82 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 163.006 | 81 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 172.421 | 82 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 149.973 | 80 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 165.946 | 82 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 151.494 | 81 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 187.753 | 83 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 171.298 | 82 |